The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses
Not Applicable
Completed
- Conditions
- Endoscopic Ultrasonography
- Registration Number
- NCT03525847
- Lead Sponsor
- Professor Dr. Seicean Andrada
- Brief Summary
A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy
- Detailed Description
A prospective study that compares the results using FNA contrast echoendoscopy versus standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- solid pancreatic tumor lesions
Exclusion Criteria
- severe coagulopathy of trombocytopenia <50.000
- patients refuse for biopsy prelevation or pacient's refuse to participate in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Diagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methods an average of 2 years Diagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methods
- Secondary Outcome Measures
Name Time Method Dysfunction in the two types of biopsies day one failure or difficulty reports with each procedure (%)
Comparison between standand endosonography and contrast enhanced endosonography in obtaining a superior quality in obtaining histology core day one Visual analogic scale
Quality of histological specimen(histology core) obtained with the two types of FNA biopsies (contrast enhanced and standard) 5 days Visual analogic scale
Trial Locations
- Locations (1)
Seicean Andrada
🇷🇴Cluj-napoca, Cluj, Romania
Seicean Andrada🇷🇴Cluj-napoca, Cluj, Romania